Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.

Tore Bjerregaard StageMagnus GraffSusan WongLouise Ladebo RasmussenFlemming NielsenAnton PottegårdKim BrøsenDeanna L KroetzS Cyrus KhojastehPer Damkier

Published in: British journal of clinical pharmacology (2018)

Dicloxacillin is an inducer of CYP2C- and CYP3A-mediated drug metabolism, and we recommend caution when prescribing dicloxacillin to users of drugs with a narrow therapeutic window.

Keyphrases

primary care
adverse drug
drug induced
electronic health record